Prelude Therapeutics (PRLD) Revenue

190 Followers

Statistics Market Cap Revenue

Prelude Therapeutics Revenue

Prelude Therapeutics had a revenue of 4.58M in the quarter ending Mar 31, 2026, with -18.79%. This bring the company's revenue in the last twelve months to 16.72M, Decreased 37.73%. In the fiscal year ending Dec 31, 2025, Prelude Therapeutics had annual revenue of 12.14M with 73.43% growth.

Revenue (ttm)

16.72M

Revenue Growth

138.86%

P/S Ratio

23.25

Revenue/Employee

$92,672

Employees

131

Market Cap

$282.25M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	12.14M	5.14M	+73.43%
Dec 31, 2024	7.00M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―